Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice.
about
Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and diseaseEffects of cholecystokinin-58 on type 1 cholecystokinin receptor function and regulationThe world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.Characterization of mice lacking the gene for cholecystokinin.Myocardial effects of VDR activators in renal failureHow does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans.The potential for vitamin D receptor activation in cardiovascular research.Molecular mechanism of vitamin D in the cardiovascular systemCombination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.Loss of vitamin D receptor produces polyuria by increasing thirst.Vitamin D and blood pressure connection: update on epidemiologic, clinical, and mechanistic evidence.Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone aloneLong-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.Is vitamin D deficiency associated with heart failure? A review of current evidence.Should hypertensive patients take vitamin D?The role of vitamin D in the prevention of type 2 diabetes. To D or not to D?The protective role of vitamin D on the heart and the kidney.Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8.Gastric vagal efferent inhibition evoked by intravenous CRF is unrelated to simultaneously recorded vagal afferent activity in urethane-anesthetized rats.Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems.Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes.Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation.Differential bile-pancreatic secretory effects of CCK-58 and CCK-8.Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties.Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat.Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria.Supramaximal CCK-58 does not induce pancreatitis in the rat: role of pancreatic water secretion.1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway.
P2860
Q24633922-383BC3A9-365E-44AA-8E85-7F6F822E12FBQ28576205-0BE77BEA-1E9B-4751-A055-CE58365D2425Q30426517-CC671ED9-B3A3-4135-AE1D-49CB15D18343Q31141388-6548F9DD-19E1-402F-BFCD-8D4E229BAF71Q34005358-4C43CEE9-968D-4414-BC80-D3373D9ED332Q36629054-C695B14B-2E73-42A1-A115-51E439164E6BQ36763989-250FDE6F-E155-465A-A21F-11ABD57DC671Q36821166-D2E58F4D-ED6C-4B49-8F30-E72F56F774FBQ36924964-4B7323E2-5710-4B0F-93FD-27C3E4A4D610Q36985814-1A54B428-6263-432B-8D73-C43A45DFF6D1Q37153808-01AEA447-5DC6-4150-980D-11CBEB7AA747Q37260870-4D78C963-FB61-4213-921E-508604505681Q37337349-DA687E50-7E6F-4DE6-B976-42988ED385DEQ37838145-092A5798-7C2B-4609-AEB1-AF2D438299D1Q38014694-C5B9EA72-FA78-41F2-88C4-E89D7D98D0AAQ38795686-913D485F-7500-4374-A7D5-DFF028FEEE55Q38991955-54C5AEE0-BAD7-49CB-89E6-F9EED22B0EBFQ42470773-FF0FB698-FDDA-458A-B122-0EE3C59760CEQ44636919-6F953BDE-E4D1-45F4-9A55-EEE18A45CC24Q45059018-20C01D08-7146-43B4-A3DB-30AB11F38716Q46335942-755D7FCE-1035-42DA-B91B-C4B60F83F5D6Q46438852-4EF3A629-F172-4BE6-A5E1-4DC216A00D88Q46599753-1E83462F-72F5-4C3B-BFBE-8024A094CE9CQ47820045-7AFBD278-F949-43F4-A466-86BD813F712CQ48379863-8C02AB76-81C4-4E33-98D1-CF38BDCB0B5AQ50433834-9A4B21A9-BBEB-4CB0-A5B7-882F9A34925BQ50705322-2FE9D0A2-5B49-40B0-9381-A0F3B76DAF2CQ51578714-7432F657-D6AA-4862-B3FC-1BA034EB4335Q54977749-3ADAFF01-15FD-4A3D-BD86-12225B04346C
P2860
Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effect of ANG II type I recept ...... vitamin D receptor-null mice.
@en
Effect of ANG II type I recept ...... vitamin D receptor-null mice.
@nl
type
label
Effect of ANG II type I recept ...... vitamin D receptor-null mice.
@en
Effect of ANG II type I recept ...... vitamin D receptor-null mice.
@nl
prefLabel
Effect of ANG II type I recept ...... vitamin D receptor-null mice.
@en
Effect of ANG II type I recept ...... vitamin D receptor-null mice.
@nl
P2860
P1476
Effect of ANG II type I recept ...... vitamin D receptor-null mice.
@en
P2093
Yan Chun Li
P2860
P304
P356
10.1152/AJPREGU.00517.2002
P577
2003-03-13T00:00:00Z